Glaucoma Trial, Recruiting NCT05874258 Sponsor: The Hong Kong Polytechnic University Condition: Glaucoma
Back to Glaucoma

Glaucoma Trial, Recruiting

NCT05874258
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 80 years old
  • People who have been diagnosed with primary open angle glaucoma or normal tension glaucoma affecting both eyes
  • People whose glaucoma has caused a specific type of partial vision loss (called a relative scotoma) in at least one eye, measured by a standard visual field test
  • People whose central (straight-ahead) vision is still reasonably good, measured at 6/12 or better on an eye chart
  • People whose vision and vision loss have been stable for at least 3 months
  • People who score 22 or above on a standard memory and thinking assessment (the Montreal Cognitive Assessment – Hong Kong version), showing their thinking and memory are largely intact

Who may not be able to join:

  • People who have other eye diseases besides glaucoma (such as age-related macular degeneration, diabetic eye disease, or moderate to severe cataracts), or who have severe hearing difficulties
  • People who have serious medical conditions such as stroke or Parkinson's disease, or who have a history of neurological conditions (such as brain surgery, brain tumour, or nerve problems), or a diagnosed cognitive condition such as dementia
  • People who have problems with balance or coordination related to the vestibular system or cerebellum, or who have a history of vertigo
  • People who are currently taking medications for neurological or psychiatric conditions (such as sedatives or sleeping tablets) that could affect movement or motor control
  • People who have medical reasons that would make a non-invasive brain stimulation procedure unsafe for them (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 852-27666108

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Hong Kong Polytechnic University
Registry
ClinicalTrials.gov
Start date
15 May 2023
Est. completion
30 June 2026

Where this trial is recruiting

Hong Kong

Primary endpoints

Visual field test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov